Q2 2026 Holdings
Filed 2026-08-14 | 82 holdings | $9.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $2.8K | 166,666 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $11.8K | 8,790 | 0.0% |
| The Oncology Institute Inc(TOIIW) | *W EXP 99/99/999 | 68236X118 | $51.0K | 1,250,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $364.3K | 917 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $705.6K | 6,027 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $1.2M | 13,702 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $2.0M | 92,787 | 0.0% |
| Alector Inc(ALEC) | COM | 014442107 | $2.1M | 1,055,192 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.3M | 583,913 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $5.9M | 101,000 | 0.1% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $8.3M | 2,534,961 | 0.1% |
| Mobia MED Inc(MOBI) | COMMON STOCK | 60705V103 | $9.0M | 670,752 | 0.1% |
| Hemab Therapeutics Hldgs Inc(COAG) | COM SHS | 423494103 | $10.1M | 275,000 | 0.1% |
| Adagene Inc(ADAG) | ADS | 005329107 | $11.2M | 2,666,666 | 0.1% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $12.2M | $13,040,000 | 0.1% |
| Spyglass Pharma Inc(SGP) | COM SHS | 85220G109 | $12.2M | 550,000 | 0.1% |
| Chemed Corp New(CHE) | COM | 16359R103 | $14.0M | 30,000 | 0.1% |
| Alamar Biosciences Inc(ALMR) | COMMON STOCK | 010911105 | $16.3M | 600,000 | 0.2% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $17.8M | 2,000,000 | 0.2% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $18.2M | 3,360,052 | 0.2% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $19.6M | 1,046,139 | 0.2% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $19.9M | 283,000 | 0.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $20.5M | 67,935 | 0.2% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $20.7M | 1,324,000 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $21.4M | 4,394,367 | 0.2% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $24.1M | 731,000 | 0.3% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $27.1M | $30,000,000 | 0.3% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $30.0M | 680,916 | 0.3% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $30.0M | 323,745 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $32.5M | 1,017,000 | 0.3% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $37.2M | 4,885,446 | 0.4% |
| Livanova PLC | NOTE 2.500% 3/1 | 53802LAB8 | $46.5M | $34,280,000 | 0.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $48.1M | 657,000 | 0.5% |
| Certara Inc(CERT) | COM | 15687V109 | $49.2M | 7,512,928 | 0.5% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $51.5M | 1,880,704 | 0.5% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $55.0M | 357,199 | 0.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $56.1M | 1,315,000 | 0.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $56.9M | 1,997,618 | 0.6% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $57.9M | 1,296,862 | 0.6% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $58.2M | 2,210,100 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $58.3M | 1,086,000 | 0.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $59.7M | 1,823,500 | 0.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $60.1M | 7,503,812 | 0.6% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $66.4M | 226,070 | 0.7% |
| Indivior Pharmaceuticals Inc(INDV) | COM | 45579U109 | $67.7M | 1,648,895 | 0.7% |
| Pfizer Inc(PFE) | COM | 717081103 | $73.2M | 3,040,000 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $76.3M | 1,332,836 | 0.8% |
| Zenas Biopharma Inc | NOTE 2.500% 4/0 | 98937LAA3 | $80.3M | $67,200,000 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $82.6M | 3,779,900 | 0.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $83.5M | 752,999 | 0.9% |